Literature DB >> 10659853

KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement.

B Huard1, L Karlsson.   

Abstract

Natural killer cell tolerance is maintained by the interaction of killer inhibitory receptors (KIRs) with self-major histocompatibility complex class I gene products. A subset of T cells also expresses inhibitory receptors, but the functional significance of these receptors on T cells is unclear. Here we show that, in the absence of T-cell receptor (TCR) engagement, KIRs expressed on CD8+ T cells are slowly downregulated by KIR ligands expressed on antigen-presenting cells. The resulting expression levels of KIR are no longer able to inhibit T-cell function. In contrast, TCR engagement sustains KIR expression, and re-induces functional levels of KIR expression after ligand-induced downregulation of KIR. Our data indicate that KIR expression on CD8+ T cells in vivo may be maintained through continuous encounters with antigen. As KIR-mediated inhibition of T-cell activation can be bypassed at high antigen concentrations, dynamic KIR expression may mediate T-cell tolerance to self-antigens by sparing self-reactive T cells, thus enabling them to mediate potentially useful immune functions to quantitatively or qualitatively different antigens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10659853     DOI: 10.1038/35002105

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  29 in total

Review 1.  Induction of T cell alertness by bacterial colonization of intestinal epithelium.

Authors:  Thomas Spies
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

Review 2.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 3.  The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.

Authors:  Francisco Borrego; Madhan Masilamani; Alina I Marusina; Xiaobin Tang; John E Coligan
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  Potential role of natural killer cell receptor-expressing cells in immunotherapy for leukemia.

Authors:  Junji Tanaka; Masahiro Asaka; Masahiro Imamura
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

Review 5.  New advances in immunotherapy for non-small cell lung cancer.

Authors:  Haifeng Qin; Fang Wang; Hui Liu; Zhen Zeng; Shasha Wang; Xin Pan; Hongjun Gao
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

6.  Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.

Authors:  P H Salim; M Jobim; M Bredemeier; J A B Chies; J Schlottfeldt; J C T Brenol; L F Jobim; R M Xavier
Journal:  Clin Exp Immunol       Date:  2010-01-15       Impact factor: 4.330

7.  Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function.

Authors:  M Nedim Ince; Brooke Harnisch; Zhan Xu; Sang-Kyung Lee; Christoph Lange; Lorenzo Moretta; Michael Lederman; Judy Lieberman
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

Review 8.  Endocytosis and intracellular trafficking of human natural killer cell receptors.

Authors:  Madhan Masilamani; Giovanna Peruzzi; Francisco Borrego; John E Coligan
Journal:  Traffic       Date:  2009-08-05       Impact factor: 6.215

9.  Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

Authors:  Ralph D Levinson; Tammy M Martin; Lihui Luo; Elham Ashouri; James T Rosenbaum; Justine R Smith; Carrie R Austin; Joseph R Lutt; Raja Rajalingam
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

10.  Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus.

Authors:  Zhenpeng Dai; Cameron J Turtle; Garrett C Booth; Stanley R Riddell; Theodore A Gooley; Anne M Stevens; Thomas Spies; Veronika Groh
Journal:  J Exp Med       Date:  2009-03-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.